Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 33480963

Efficacy of Margetuximab vs Trastuzumab in Patients With Pretreated ERBB2-Positive Advanced Breast Cancer: A Phase 3 Randomized Clinical Trial.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
JAMA Oncol
Publication date
2021 Apr 1
First author
Rugo HS

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships

    Authors and identifiers

    1. name
      Rugo HS
      type
      Author
    2. name
      Im SA
      type
      Author
    3. name
      Cardoso F
      type
      Author
    4. name
      Cortés J
      type
      Author
    5. name
      Curigliano G
      type
      Author
    6. name
      Musolino A
      type
      Author
    7. name
      Pegram MD
      type
      Author
    8. name
      Wright GS
      type
      Author
    9. name
      Saura C
      type
      Author
    10. name
      Escrivá-de-Romaní S
      type
      Author
    11. name
      De Laurentiis M
      type
      Author
    12. name
      Levy C
      type
      Author
    Complete bibliographic record and source provenance
    authors
    1. name
      Rugo HS
      type
      Author
    2. name
      Im SA
      type
      Author
    3. name
      Cardoso F
      type
      Author
    4. name
      Cortés J
      type
      Author
    5. name
      Curigliano G
      type
      Author
    6. name
      Musolino A
      type
      Author
    7. name
      Pegram MD
      type
      Author
    8. name
      Wright GS
      type
      Author
    9. name
      Saura C
      type
      Author
    10. name
      Escrivá-de-Romaní S
      type
      Author
    11. name
      De Laurentiis M
      type
      Author
    12. name
      Levy C
      type
      Author
    bibliography ids
    1. nci-bib-d849b17c961831bb005d2c69
    book metadata
    content sha256
    05d84ee0b6c010f98d79af3a22699d79aec82c4054fd8d9dd9e770ec5428ba91
    document type
    citation
    dois
    1. 10.1001/jamaoncol.2020.7932
    electronic publication date
    display
    Source null
    precision
    missing
    year
    Source null
    evidence scope
    bibliographic_metadata_only
    id
    pubmed:33480963
    immutable id
    pubmed:33480963@05d84ee0b6c010f98d79af3a22699d79aec82c4054fd8d9dd9e770ec5428ba91
    journal
    abbreviation
    JAMA Oncol
    issn electronic
    2374-2445
    issn print
    2374-2437
    issue
    4
    name
    JAMA oncology
    nlm unique id
    101652861
    pages
    573-584
    volume
    7
    languages
    1. eng
    notices
    absence is not clearance
    true
    has correction metadata
    false
    has expression of concern metadata
    false
    has retraction in link
    false
    pubmed marks article retracted
    false
    pubmed marks retraction notice
    false
    relationships
      outcomes validated
      false
      pmid
      33480963
      provenance
      batch id
      9bca82d1bba2b27adc79
      provider
      NCBI PubMed ESummary
      record sha256
      94e32d2ed2c2d7a3639b43fbb924ee10e8263fa58093b1302edd6d76312cfded
      response sha256
      c8a4853c65a45038af15f5ade3970763bfa121cf5c68bafcc52c3a06860d0211
      retrieved at
      2026-09-09T23:47:56.131551+00:00
      publication date
      display
      2021 Apr 1
      precision
      day
      year
      2021
      publication types
      1. Clinical Trial, Phase III
      2. Journal Article
      3. Randomized Controlled Trial
      4. Research Support, Non-U.S. Gov't
      record status
      PubMed - indexed for MEDLINE
      schema version
      1.0
      source url
      https://pubmed.ncbi.nlm.nih.gov/33480963/
      title
      Efficacy of Margetuximab vs Trastuzumab in Patients With Pretreated ERBB2-Positive Advanced Breast Cancer: A Phase 3 Randomized Clinical Trial.

      Preserved source evidence · Not medical advice